Theriva Biologics (TOVX) Sof foyda bo'yicha sotuv rentabelligi

Theriva Biologics, Inc. (TOVX) tovar belgisi

Theriva Biologics, Inc. (TOVX) o'smalarga qarshi kurashish uchun adenoviruslarni ishlab chiqishda mustahkam obro'ga ega. Sof foyda marjasi ushbu bosqichni tasdiqlaydi, bunda ko'rsatkich qiymati -3412.70 ni tashkil etadi. Mikrobiom tadqiqotlarining diversifikatsiyasi xatarlarni kamaytirsa-da, rivojlanishning joriy bosqichi qimmatbaho ilmiy tadqiqotlarni moliyalashtirish uchun mavjud zaxiralarning asta-sekin kamayishiga tayanadi.

TOVX: Theriva Corp Kompaniyaning sof rentabelligi 28.04.2023 - 20.11.2026

Theriva Biologics, Inc. kompaniyasining tahliliy kesimlari

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahliliyoti:therivabio.com - TOVX
Synthetic Biologics yetakchi tovari

Theriva Biologics, Inc. (TOVX) kompaniyasining barqarorligi klinik sinovlar yakunlanishigacha kapitalni saqlab qolish qobiliyati bilan belgilanadi. Sof foyda marjasi tendentsiyasi tijorat daromadlari mavjud bo'lmagan sharoitda xarajatlarni boshqarish samaradorligini aks ettiradi. Ushbu ko'rsatkich tushumda qoldiq daromadning ulushini o'lchab, biznesning bozor zarbalarini yumshatish qobiliyatini ochib beradi. Kam uchraydigan kasalliklar statusiga ega bo'lgan biotexnologiya kompaniyasi uchun ushbu ko'rsatkich operatsion yashab qolish markeriga xizmat qiladi. Uning barqarorligi kelajakdagi kapitalizatsiyaning adolatli baholanishiga bevosita ta'sir ko'rsatadi.

Raqobatchilar tahlili

NantKwest (IBRX) - Sof marja|Sof marja Immunocore PLC (IMCR)|Sof foyda bo'yicha sotuv rentabelligi JANX|RCUS - Sof foyda bo'yicha marjinallik|Sof foyda bo'yicha sotuv rentabelligi ZYME (Zymeworks Corp)|Kompaniyaning sof rentabelligi TNGX|Sotuvning sof marjinal rentabelligi IOVA (Iovance Biotherapeutics, Inc.)|Sof foyda normasi IMTX|xencor.com - Sotuvning sof marjinal rentabelligi|Sof marja Compass Therapeutics Corp|Replimune Group, Inc. (REPL) - Sof marja|Lyell Immunopharma - Sof foyda normasi|IPHA (innate-pharma.com) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi pyxisoncology.com|Sof marja cgen.com (CGEN)|IOBT: Sof foyda marjasi|Sutro Biopharma Inc. - Sof foyda bo'yicha sotuv rentabelligi|minktherapeutics.com (INKT) - Sof marja|HOWL: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi Immix Biopharma IMMX|ALX Oncology (ALXO) - Sof marja|Sof marja Cue Biopharma, Inc. (CUE)|Sof marja PDS Biotechnology Corporation|Sotuvning sof rentabelligi SONN (sonnetbio.com)|Sotuvning sof marjinal rentabelligi MAIA|Kompaniya sotuv marjasi Liminatus Pharma Inc.|LAVA Therapeutics N.V. - Sof foyda bo'yicha sotuv rentabelligi|NXTC - Sof foyda bo'yicha sotuv rentabelligi|LPTX: Sof foyda bo'yicha sotuv rentabelligi|Kompaniya sotuv marjasi intensitytherapeutics.com INTS|SNSE (Sensei Bio) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Gritstone Bio (GRTS)|KA (Kineta Corp) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi NEXI (NexImmune Corp)|Sotuvning sof marjinal rentabelligi TSBX|VCNX (Vaccinex, Inc.) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi HARP (Harpoon Therapeutics, Inc.)